Cytosorbents
CTSO
$0.94
Share price
0.00%
Change (1 day)
-4.08%
Change (1 year)
Categories
Revenue for Cytosorbents (CTSO)
Revenue in 2024 (TTM): $35.59 Million USD
According to Cytosorbents's latest financial reports the company's current revenue (TTM 
) is $35.59 Million USD. an increase over the revenue in the year 2023 that were of $31.08 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cytosorbents from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $35.59 M | 14.51% |
| 2023 | $31.08 M | 5.88% |
| 2022 | $29.35 M | -26.8% |
| 2021 | $40.1 M | 1.66% |
| 2020 | $39.45 M | 73.3% |
| 2019 | $22.76 M | 12.41% |
| 2018 | $20.25 M | 51.34% |
| 2017 | $13.38 M | 63.07% |
| 2016 | $8.2 M | 102.33% |
| 2015 | $4.05 M | 28.98% |
| 2014 | $3.14 M | 282.65% |
| 2013 | $0.82 M | -257% |
| 2012 | -$0.53 Million | -1550.82% |
| 2011 | $0.03 M | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $0.33 B | 835.59% | 🇺🇸 USA |
 | $4.03 B | 11,247.25% | 🇺🇸 USA |
 | $16.74 B | 46,946.57% | 🇺🇸 USA |